Galmed Pharmaceuticals Ltd

CUSIP M47238148SHSGLMDQ1 2026

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

9.9%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

4 filings · latest Nov 7, 2025

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Nov 7, 2025	Cvi Investments, Inc.	13G/A	3.1%	173.3K	SEC
2	Aug 14, 2025	Cvi Investments, Inc.	13G/A	7.1%	173.3K	SEC
3	Feb 18, 2025	Allen Baharaff	13G/A	2.6%	44.2K	SEC
4	Nov 14, 2024	Cvi Investments, Inc.	13G/A	9.9%	167.3K	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Two Sigma Investments, LP	80.2K	$39.3K
2	Xtx Topco Ltd	22.4K	$10.8K
3	Jane Street Group, LLC	16.4K	$8.1K
4	Two Sigma Securities, LLC	12.0K	$5.9K
5	Citadel Advisors LLC	11.4K	$5.5K
6	Ubs Group AG	2.5K	$1.2K
7	Bnp Paribas Financial Markets	600	$294
8	Morgan Stanley	157	$77
9	Wells Fargo & Company/Mn	43	$21
10	Sbi Securities Co., Ltd.	16	$8